Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

From the authors:

J. P. de Torres, C. Casanova, B. R. Celli
European Respiratory Journal 2009 34: 289; DOI: 10.1183/09031936.00061409
J. P. de Torres
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C. Casanova
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
B. R. Celli
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

We appreciate the comments of T. Lahm about our recently published article 1. He suggests that one possible explanation for the better survival observed in females with chronic obstructive pulmonary disease (COPD) compared to that of males with COPD may be the presence of less severe hypoxemic vasoconstriction and, therefore, pulmonary hypertension (PH) and/or right ventricular hypertrophy in females compared with males. Although he provides indirect evidence to support his comments, we have a few problems with this mechanism being an important one. This is based on the fact that in our study population only 18% of participants had Global Obstructive Chronic Lung Disease stage IV and 12% were in quartile 4 of the BODE (body mass index, airflow obstruction, dyspnoea, exercise capacity) index, usually the type of individuals that develop hypoxaemia and PH. In fact, only 25 patients (∼5%) from our population were on long-term oxygen therapy, which would be the population where the likelihood of cor pulmonale is highest. However, the difference in mortality between females and males persisted across disease severity. Conversely, we do agree with his comments regarding the more severe patients, especially those with hypoxaemia, as was previously shown by the works of the Miyamoto et al. 2, Crockett et al. 3 and Franklin et al 4.

A problem with T. Lahm's theory is that females with obstructive sleep apnoea syndrome have a higher mortality than males with obstructive sleep apnoea syndrome 5, 6. If we accept that sleep apnoea represents an example of intermittent hypoxaemia and increased pulmonary artery pressure, and is usually associated with right ventricular hypertrophy and adipose tissue, T. Lahm's proposed theory to explain the better survival effect in females with COPD is not quite that clear.

Greater effort in the research field is needed in order to clarify the increasingly important issue of sex and disease expression. However, the interesting hypothesis proposed by T. Lahm sheds more light on to this dark field; we are thankful for his insight.

Statement of interest

None declared.

    • © ERS Journals Ltd

    References

    1. ↵
      de Torres JP, Cote CG, López MV, et al. Sex differences in mortality in patients with COPD. Eur Respir J 2009;33:528–535.
      OpenUrlAbstract/FREE Full Text
    2. ↵
      Miyamoto K, Aida A, Nishimura M, et al. Gender effect on prognosis of patients receiving long-term home oxygen therapy. The Respiratory Failure Research Group in Japan. Am J Respir Crit Care Med 1995;152:972–976.
      OpenUrlPubMedWeb of Science
    3. ↵
      Crockett AJ, Cranston JM, Moss JR, et al. Survival on long-term oxygen therapy in chronic airflow limitation: from evidence to outcomes in the routine clinical setting. Intern Med J 2001;31:448–454.
      OpenUrlCrossRefPubMedWeb of Science
    4. ↵
      Franklin KA., Gustafson T., Ranstam J., et al. Survival and future need of long-term oxygen therapy for chronic obstructive pulmonary disease: gender differences. Respir Med 2007;101:1506–1511.
      OpenUrlCrossRefPubMedWeb of Science
    5. ↵
      Morrish E, Shneerson JM, Smith IE. Why does gender influence survival in obstructive sleep apnoea? Respir Med 2008;102:1231–1236.
      OpenUrlCrossRefPubMedWeb of Science
    6. ↵
      Young T, Finn L. Epidemiological insights into the public health burden of sleep disordered breathing: sex differences in survival among sleep clinic patients. Thorax 1998;53: Suppl. 3 S16–S19.
      OpenUrlFREE Full Text
    PreviousNext
    Back to top
    View this article with LENS
    Vol 34 Issue 1 Table of Contents
    European Respiratory Journal: 34 (1)
    • Table of Contents
    • Index by author
    Email

    Thank you for your interest in spreading the word on European Respiratory Society .

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    From the authors:
    (Your Name) has sent you a message from European Respiratory Society
    (Your Name) thought you would like to see the European Respiratory Society web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Print
    Citation Tools
    From the authors:
    J. P. de Torres, C. Casanova, B. R. Celli
    European Respiratory Journal Jul 2009, 34 (1) 289; DOI: 10.1183/09031936.00061409

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero

    Share
    From the authors:
    J. P. de Torres, C. Casanova, B. R. Celli
    European Respiratory Journal Jul 2009, 34 (1) 289; DOI: 10.1183/09031936.00061409
    del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
    Full Text (PDF)

    Jump To

    • Article
      • Statement of interest
      • References
    • Info & Metrics
    • PDF
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    More in this TOC Section

    • Risk factors for disease progression in fibrotic hypersensitivity pneumonitis
    • Optimised surveillance of bronchial dysplasia in risky population
    • Reply: Risk factors for disease progression in fibrotic hypersensitivity pneumonitis
    Show more Correspondence

    Related Articles

    Navigate

    • Home
    • Current issue
    • Archive

    About the ERJ

    • Journal information
    • Editorial board
    • Reviewers
    • Press
    • Permissions and reprints
    • Advertising

    The European Respiratory Society

    • Society home
    • myERS
    • Privacy policy
    • Accessibility

    ERS publications

    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS books online
    • ERS Bookshop

    Help

    • Feedback

    For authors

    • Instructions for authors
    • Publication ethics and malpractice
    • Submit a manuscript

    For readers

    • Alerts
    • Subjects
    • Podcasts
    • RSS

    Subscriptions

    • Accessing the ERS publications

    Contact us

    European Respiratory Society
    442 Glossop Road
    Sheffield S10 2PX
    United Kingdom
    Tel: +44 114 2672860
    Email: journals@ersnet.org

    ISSN

    Print ISSN:  0903-1936
    Online ISSN: 1399-3003

    Copyright © 2023 by the European Respiratory Society